A431电池
自磷酸化
表皮生长因子
酪氨酸激酶
生物
癌基因
癌症研究
酪氨酸磷酸化
表皮生长因子受体
癌细胞
细胞生长
激酶
细胞周期
癌症
细胞生物学
细胞
信号转导
受体
蛋白激酶A
生物化学
遗传学
作者
Kaladhar B. Reddy,Venkateshwar G. Keshamouni,Yong Q. Chen
摘要
It is well documented that epidermal growth factor (EGF) inhibits proliferation of A431 and MDA-468 cells via activation of p21/WAF1. In the present study, we have shown that treatment of MDA-468 and A431 cells that express high levels of EGFR with 100 ng/ml of EGF leads to 14.9-fold increase in epidermal growth factor receptor (EGFR) autophosphorylation and high levels of p21/WAF1-induction (6. 7-fold), down regulation of cdk2 activity and growth arrest. When MDA-468 or A431 cells were simultaneously treated with 100 ng/ml EGF and RG13022, a relatively specific tyrosine kinase inhibitor, there was a significant reduction in p21/WAF1 levels. In contrast, when MDA-468, A432 cells that are treated with low levels of EGF (10 ng/ml) or other cells which express low to moderate levels of EGFRs such as MCF-7, MCF-10A, MDA-231 and SKBR-3 breast cells were exposed to 100 ng/ml of EGF there was a 3.8-fold increase in EGFR autophosphorylation, leading to 1.6-fold induction of p21/WAF1 and increased cell proliferation. These results suggest that the level of EGFR tyrosine kinase activity may regulate p21/WAF1 induction in cancer cells.
科研通智能强力驱动
Strongly Powered by AbleSci AI